Pharmaceutical GMP readiness in Brazil
Brazil's ANVISA (Agência Nacional de Vigilância Sanitária) regulates medicines under Law 6.360/1976 and a series of Resolutions of the Collegiate Board (RDCs). The current GMP regulation is RDC 658/2022 (in force from 2022, replacing RDC 301/2019), aligned with PIC/S GMP — Brazil became a PIC/S member in 2021. Every manufacturing site (domestic or foreign) supplying Brazil needs a Certificate of Good Manufacturing Practices (CBPF) from ANVISA. Serialization is mandatory under the Sistema Nacional de Controle de Medicamentos (SNCM). This guide covers the Brazil-specific layer.
Regulator and legal basis
Registration and CBPF
SNCM serialization and dossier language
Inspection style and common findings
A 90–180 day Brazil readiness path
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
The international model for a Pharmaceutical Quality System covering the entire product lifecycle from development to discontinuation.
ICH Q1A(R2) is the global stability-study framework adopted by FDA, EMA, MHRA, PMDA, Health Canada, and (via WHO TRS 1010) most ROW regulators.
EU GMP Annex 1 (revision effective 25 August 2023, with full lyophilisation-section compliance from 25 August 2024) is the world's most influential sterile-manufacturing standard — adopted by EU, MHRA
The nine-letter mnemonic regulators use to grade your data integrity — and what every Part 11 audit really tests.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
How long is the CBPF inspection queue?
What is a DIFA?
What stability zone applies to Brazil?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
- Australia pharmaceutical GMP readiness — TGA, PIC/S GMP, ARTG
- Canada pharmaceutical GMP readiness — Health Canada, FDR Div. 2, DEL
- China pharmaceutical GMP readiness — NMPA, Drug Administration Law, 2010 GMP
- EU pharmaceutical GMP readiness — EudraLex Vol 4, QP release, EU GDP
- GCC pharmaceutical GMP readiness — Saudi SFDA, GCC-DR, UAE MOHAP, RSD
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
- India pharmaceutical GMP readiness — CDSCO, Schedule M, Drugs and Cosmetics Act
